Ameriprise Financial Inc Catalyst Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$356 Billion
Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 269,178 shares of CPRX stock, worth $6.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

269,178

Previous 282,834 4.83%

Holding current value

$6.72 Million

Previous $5.9 Million 10.59%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$19.53 - $25.74 $266,701 - $351,505	-13,656 Reduced 4.83%	269,178 $6.53 Million
Q4 2024 Feb 14, 2025	BUY	$19.73 - $23.93 $102,142 - $123,885	5,177 Added 1.86%	282,834 $5.9 Million
Q3 2024 Nov 14, 2024	SELL	$15.19 - $21.35 $597,240 - $839,439	-39,318 Reduced 12.4%	277,657 $5.52 Million
Q2 2024 Aug 14, 2024	SELL	$14.68 - $16.92 $945,025 - $1.09 Million	-64,375 Reduced 16.88%	316,975 $4.91 Million
Q1 2024 May 15, 2024	SELL	$13.18 - $17.11 $934,264 - $1.21 Million	-70,885 Reduced 15.67%	381,350 $6.08 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $417,907 - $613,380	35,476 Added 8.51%	452,235 $7.6 Million
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $236,243 - $303,539	-20,209 Reduced 4.62%	416,759 $4.87 Million
Q2 2023 Aug 14, 2023	SELL	$11.5 - $18.08 $210,116 - $330,339	-18,271 Reduced 4.01%	436,968 $5.87 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $2.6 Million - $3.82 Million	-181,502 Reduced 28.5%	455,239 $7.55 Million
Q4 2022 Feb 14, 2023	BUY	$12.25 - $19.5 $176,228 - $280,527	14,386 Added 2.31%	636,741 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $2.92 Million - $6.43 Million	414,034 Added 198.75%	622,355 $7.99 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $70,031 - $96,335	11,241 Added 5.7%	208,321 $1.46 Million
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $1.81 Million - $2.84 Million	-341,779 Reduced 63.43%	197,080 $1.63 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $2.49 Million - $3.56 Million	477,832 Added 782.98%	538,859 $3.65 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $295,980 - $368,603	61,027 New	61,027 $324,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $46,996 - $66,277	-10,955 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.97 - $3.83 $53,195 - $68,599	-17,911 Reduced 62.05%	10,955 $37,000
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $6,159 - $10,535	2,074 Added 7.74%	28,866 $86,000
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $93,236 - $135,299	26,792 New	26,792 $124,000
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $817,274 - $1.37 Million	-341,956 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$2.51 - $4.4 $858,309 - $1.5 Million	341,956	341,956 $1.34 Million

Others Institutions Holding CPRX

# of Institutions

389

Shares Held

99.3M

Call Options Held

37K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.57B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Catalyst Pharmaceuticals, Inc. Transaction History